Elisa Corporation/ FI0009007884 /
2024-07-26 5:29:36 PM | Chg. +0.16 | Volume | Bid5:29:36 PM | Ask5:29:36 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
42.84EUR | +0.37% | 149,508 Turnover: 6.34 mill. |
42.88Bid Size: 60 | 42.98Ask Size: 51 | 6.87 bill.EUR | 5.25% | 18.31 |
GlobeNewswire
06-02
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
06-01
First Federal Savings Bank and ICBA Offer Tips to Help Simplify the Homebuying Process
GlobeNewswire
05-31
CertiK Announces the Launch of CertiK Ventures to Shape the Future of Onchain Innovation
GlobeNewswire
05-14
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
GlobeNewswire
03-11
Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitratio...
GlobeNewswire
03-04
Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2...
GlobeNewswire
02-26
Nokia’s anyRAN broadens options for commercial Cloud RAN deployment and targets enterprises with par...
GlobeNewswire
02-22
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
02-13
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality...